{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:22:50Z","timestamp":1793830970163,"version":"4.6.1"},"reference-count":135,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic Lupus Erythematosus (SLE) is a multifaceted, multisystem autoimmune disorder with diverse clinical expressions. While prevalence reports vary widely, pulmonary involvement accounts for significant morbidity and mortality in SLE. This comprehensive review explores the spectrum of pulmonary disease in SLE, including upper airway manifestations (e.g., laryngeal affection), lower airway conditions (e.g., bronchitis, bronchiolitis, bronchiectasis), parenchymal diseases (e.g., interstitial lung disease, acute lupus pneumonitis, diffuse alveolar hemorrhage), pleural diseases (e.g., serositis, shrinking lung syndrome), and vascular diseases (e.g., pulmonary arterial hypertension, pulmonary embolism, acute reversible hypoxemia syndrome). We discuss diagnostic modalities, treatment strategies, and prognosis for each pulmonary manifestation. With diagnostics remaining a challenge and with the absence of standardized treatment guidelines, we emphasize the need for evidence-based guidelines to optimize patient care and improve outcomes in this complex disease.<\/jats:p>","DOI":"10.1055\/s-0044-1782653","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T19:55:08Z","timestamp":1711655708000},"page":"386-396","source":"Crossref","is-referenced-by-count":21,"title":["Systemic Lupus Erythematosus-related Lung Disease"],"prefix":"10.1055","volume":"45","author":[{"given":"Elisabeth","family":"Bendstrup","sequence":"additional","affiliation":[{"name":"Center for Rare Lung Disease, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Lynn","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Troldborg","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Biomedicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"A Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"09","key":"ref2","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 EULAR\/ACR Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"M Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.reumae.2018.03.001","article-title":"Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage","volume":"14","author":"G Aguilera-Pickens","year":"2018","journal-title":"Reumatol Cl\u00edn (Engl Ed)"},{"issue":"05","key":"ref4","first-page":"396","article-title":"On the visceral manifestations of the erythema group of skin diseases [Third Paper.] 1904","volume":"338","author":"W Osler","year":"2009","journal-title":"Am J Med Sci"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1573397113666170704102444","article-title":"Cardiovascular and pulmonary manifestations of systemic lupus erythematosus","volume":"13","author":"K Tselios","year":"2017","journal-title":"Curr Rheumatol Rev"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0039-1685537","article-title":"Pulmonary complications of systemic lupus erythematosus","volume":"40","author":"J R Hannah","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccm.2010.05.001","article-title":"Pulmonary manifestations of systemic lupus erythematosus","volume":"31","author":"D L Kamen","year":"2010","journal-title":"Clin Chest Med"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13075-018-1776-8","article-title":"Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort","volume":"20","author":"J Narv\u00e1ez","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"derivation of the sledai. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"D D Gladman","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1378\/chest.88.1.129","article-title":"Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications","volume":"88","author":"A Pines","year":"1985","journal-title":"Chest"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0961203307079042","article-title":"Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage","volume":"16","author":"A M Bertoli","year":"2007","journal-title":"Lupus"},{"issue":"13","key":"ref12","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1177\/0961203317699284","article-title":"Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL)","volume":"26","author":"M J Haye Salinas","year":"2017","journal-title":"Lupus"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/ph14030276","article-title":"Respiratory manifestations in systemic lupus erythematosus","volume":"14","author":"S Di Bartolomeo","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PHM.0b013e31815b669e","article-title":"Recurrent laryngeal neuropathy in a systemic lupus erythematosus (SLE) patient","volume":"87","author":"J H Lee","year":"2008","journal-title":"Am J Phys Med Rehabil"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0049-0172(92)90020-E","article-title":"Laryngeal involvement in systemic lupus erythematosus","volume":"22","author":"A D Teitel","year":"1992","journal-title":"Semin Arthritis Rheum"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1378\/chest.121.3.990","article-title":"Severe upper airway obstruction from cricoarytenoiditis as the sole presenting manifestation of a systemic lupus erythematosus flare","volume":"121","author":"A Karim","year":"2002","journal-title":"Chest"},{"issue":"24","key":"ref17","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1001\/jama.1980.03310240043023","article-title":"Rheumatoid nodules of the vocal cords as the initial manifestation of systemic lupus erythematosus","volume":"244","author":"I S Schwartz","year":"1980","journal-title":"JAMA"},{"issue":"02","key":"ref18","first-page":"157","article-title":"Systemic and discoid lupus erythematosus: analysis of pulmonary function","volume":"51","author":"D Wohlgelernter","year":"1978","journal-title":"Yale J Biol Med"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1378\/chest.94.2.312","article-title":"Pulmonary function of nonsmoking patients with systemic lupus erythematosus","volume":"94","author":"A P Andonopoulos","year":"1988","journal-title":"Chest"},{"issue":"08","key":"ref20","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.rmr.2010.01.003","article-title":"Respiratory involvement in systemic lupus erythematosus","volume":"27","author":"D Carmier","year":"2010","journal-title":"Rev Mal Respir"},{"issue":"05","key":"ref21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1378\/chest.82.5.646","article-title":"Bronchiolitis in systemic lupus erythematosus","volume":"82","author":"W W Kinney","year":"1982","journal-title":"Chest"},{"issue":"10","key":"ref22","first-page":"1289","article-title":"[Respiratory involvement in systemic lupus erythematosus]","volume":"25","author":"D Carmier","year":"2008","journal-title":"Rev Mal Respir"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5606\/ArchRheumatol.2019.7149","article-title":"Systemic lupus erythematosus and angioedema: a cross-sectional study from the national inpatient sample","volume":"34","author":"Y Luo","year":"2019","journal-title":"Arch Rheumatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"bcr2018224222","DOI":"10.1136\/bcr-2018-224222","article-title":"Angioedema as the presenting feature of systemic lupus erythematosus","volume":"2018","author":"N Kumar","year":"2018","journal-title":"BMJ Case Rep"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"bcr2017221652","DOI":"10.1136\/bcr-2017-221652","article-title":"Lupus of the larynx: when bamboo nodes lead to diagnosis\u2026","volume":"2018","author":"J Todic","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1148\/radiology.196.3.7644652","article-title":"Discrete lung involvement in systemic lupus erythematosus: CT assessment","volume":"196","author":"A A Bankier","year":"1995","journal-title":"Radiology"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0009-9260(97)80159-6","article-title":"Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT","volume":"52","author":"G C Ooi","year":"1997","journal-title":"Clin Radiol"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2214\/ajr.166.2.8553934","article-title":"High-resolution chest CT in systemic lupus erythematosus","volume":"166","author":"H M Fenlon","year":"1996","journal-title":"AJR Am J Roentgenol"},{"issue":"02","key":"ref29","first-page":"187","article-title":"Pulmonary dysfunction in systemic lupus erythematosus:prevalence classification and correlation with other organ involvement","volume":"7","author":"S L Silberstein","year":"1980","journal-title":"J Rheumatol"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1378\/chest.94.1.129","article-title":"Serial pulmonary function testing in patients with systemic lupus erythematosus","volume":"94","author":"P Q Eichacker","year":"1988","journal-title":"Chest"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/096120339600500108","article-title":"Respiratory function in systemic lupus erythematosus: relation with activity and severity","volume":"5","author":"G Rolla","year":"1996","journal-title":"Lupus"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/resp.14268","article-title":"Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: a nation-wide population-based study over 10\u2009years","volume":"27","author":"A Mageau","year":"2022","journal-title":"Respirology"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0049-0172(90)90094-V","article-title":"A long-term study of interstitial lung disease in systemic lupus erythematosus","volume":"20","author":"L Weinrib","year":"1990","journal-title":"Semin Arthritis Rheum"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1038\/s41598-019-43782-7","article-title":"Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study","volume":"9","author":"N Enomoto","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"ref35","first-page":"11","article-title":"Pulmonary involvement in systemic lupus erythematosus patients in a tertiary care hospital","volume":"70","author":"D Sahu","year":"2022","journal-title":"J Assoc Physicians India"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-9343(81)90366-1","article-title":"The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients","volume":"71","author":"H M Haupt","year":"1981","journal-title":"Am J Med"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.resinv.2021.04.011","article-title":"2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease","volume":"59","author":"Y Kondoh","year":"2021","journal-title":"Respir Investig"},{"issue":"18","key":"ref38","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"K R Flaherty","year":"2019","journal-title":"N Engl J Med"},{"issue":"13","key":"ref39","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0961203316646461","article-title":"Lupus pneumonitis as the initial presentation of systemic lupus erythematosus: case series from a single institution","volume":"25","author":"S A Wan","year":"2016","journal-title":"Lupus"},{"issue":"05","key":"ref40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005792-197509000-00003","article-title":"Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis","volume":"54","author":"R A Matthay","year":"1975","journal-title":"Medicine (Baltimore)"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1398-9995.2005.00761.x","article-title":"The respiratory system in connective tissue disorders","volume":"60","author":"B Crestani","year":"2005","journal-title":"Allergy"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s12098-007-0190-z","article-title":"Intravenous immunoglobulin therapy of lupus pneumonitis","volume":"74","author":"G Chetan","year":"2007","journal-title":"Indian J Pediatr"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1445-5994.2006.01055.x","article-title":"Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports","volume":"36","author":"S W Lim","year":"2006","journal-title":"Intern Med J"},{"issue":"08","key":"ref44","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/09612033231180704","article-title":"Diffuse alveolar haemorrhage in systemic lupus erythematosus: a multicentre retrospective study in Singapore","volume":"32","author":"A HN Law","year":"2023","journal-title":"Lupus"},{"issue":"06","key":"ref45","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.semarthrit.2016.09.004","article-title":"Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus","volume":"46","author":"D Kim","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0961203315605365","article-title":"Alveolar hemorrhage in systemic lupus erythematosus: a cohort review","volume":"25","author":"C Andrade","year":"2016","journal-title":"Lupus"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12016-019-08763-8","article-title":"Clinical characteristics and risk factors of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis based on observational studies","volume":"59","author":"T Xu","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0961203310381511","article-title":"Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea","volume":"20","author":"S K Kwok","year":"2011","journal-title":"Lupus"},{"issue":"08","key":"ref49","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3899\/jrheum.130927","article-title":"Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage","volume":"41","author":"M U Martinez-Martinez","year":"2014","journal-title":"J Rheumatol"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0961203307086930","article-title":"High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage","volume":"17","author":"J Rojas-Serrano","year":"2008","journal-title":"Lupus"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.berh.2009.01.002","article-title":"Respiratory manifestations of systemic lupus erythematosus: old and new concepts","volume":"23","author":"J M Pego-Reigosa","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"06","key":"ref52","first-page":"714","article-title":"Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies","volume":"84","author":"J T Good Jr","year":"1983","journal-title":"Chest"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0961203314555171","article-title":"Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis","volume":"24","author":"B Y Choi","year":"2015","journal-title":"Lupus"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"610257","DOI":"10.3389\/fmed.2020.610257","article-title":"Lupus and the lungs: the assessment and management of pulmonary manifestations of systemic lupus erythematosus","volume":"7","author":"R Amarnani","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00063198-200207000-00012","article-title":"Diagnosis and management of lupus pleuritis","volume":"8","author":"D Y Wang","year":"2002","journal-title":"Curr Opin Pulm Med"},{"issue":"03","key":"ref56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/resp.12473","article-title":"Pulmonary manifestations in systemic lupus erythematosus: association with disease activity","volume":"20","author":"O SB Alamoudi","year":"2015","journal-title":"Respirology"},{"issue":"05","key":"ref57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1155\/2002\/740878","article-title":"Fibrothorax and severe lung restriction secondary to lupus pleuritis and its successful treatment by pleurectomy","volume":"9","author":"S Sharma","year":"2002","journal-title":"Can Respir J"},{"issue":"08","key":"ref58","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/RHU.0000000000000179","article-title":"Etiologies and outcomes of pleural effusions in patients with systemic lupus erythematosus","volume":"20","author":"N Palavutitotai","year":"2014","journal-title":"J Clin Rheumatol"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"A Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"ref60","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.1780341121","article-title":"Successful use of tetracycline pleurodesis to treat massive pleural effusion secondary to systemic lupus erythematosus","volume":"34","author":"K M McKnight","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1378\/chest.117.5.1404","article-title":"Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion","volume":"117","author":"M Glazer","year":"2000","journal-title":"Chest"},{"issue":"5445","key":"ref62","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/bmj.1.5445.1273","article-title":"\u201cUnexplained\u201d dyspnoea and shrinking lungs in systemic lupus erythematosus","volume":"1","author":"B I Hoffbrand","year":"1965","journal-title":"BMJ"},{"issue":"10","key":"ref63","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.autrev.2016.07.021","article-title":"Shrinking lung syndrome associated with systemic lupus erythematosus: a multicenter collaborative study of 15 new cases and a review of the 155 cases in the literature focusing on treatment response and long-term outcomes","volume":"15","author":"L Duron","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semarthrit.2008.04.003","article-title":"Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: a systematic review","volume":"39","author":"S P Toya","year":"2009","journal-title":"Semin Arthritis Rheum"},{"issue":"03","key":"ref65","first-page":"262","article-title":"Pulmonary dysfunction in systemic lupus erythematosus without pulmonary symptoms","volume":"3","author":"T W Chick","year":"1976","journal-title":"J Rheumatol"},{"issue":"04","key":"ref66","first-page":"e24320","article-title":"Shrinking lung syndrome in a young female: a rare pulmonary manifestation of systemic lupus erythematosus","volume":"14","author":"M R Almajed","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"ref67","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/1529-0131(199910)42:10<2249::AID-ANR31>3.0.CO;2-4","article-title":"Shrinking lung in primary Sj\u00f6gren's syndrome","volume":"42","author":"A Tavoni","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1529-0131(200101)44:1<243::AID-ANR36>3.0.CO;2-L","article-title":"Shrinking lung syndrome in patients without systemic lupus erythematosus: comment on the concise communication by Tavoni et al","volume":"44","author":"S Ahmed","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"06","key":"ref69","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00124743-200212000-00011","article-title":"Shrinking lung syndrome in systemic lupus erythematosus and Sjogren's syndrome","volume":"8","author":"R Singh","year":"2002","journal-title":"J Clin Rheumatol"},{"issue":"10","key":"ref70","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1002\/art.11393","article-title":"Shrinking lung syndrome in systemic sclerosis","volume":"48","author":"C A Scir\u00e8","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"05","key":"ref71","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00296-011-1863-5","article-title":"Presentation and prognosis of shrinking lung syndrome in systemic lupus erythematosus: report of four cases","volume":"32","author":"D C Calderaro","year":"2012","journal-title":"Rheumatol Int"},{"issue":"05","key":"ref72","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0025-6196(11)64215-8","article-title":"The shrinking lungs syndrome in systemic lupus erythematosus","volume":"75","author":"K J Warrington","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"04","key":"ref73","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.119.4.1274","article-title":"Bilateral phrenic paralysis in a patient with systemic lupus erythematosus","volume":"119","author":"K Hardy","year":"2001","journal-title":"Chest"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/qjmed\/hcq095","article-title":"Shrinking lung syndrome caused by lupus myopathy","volume":"104","author":"L A P\u00e9rez-de-Llano","year":"2011","journal-title":"QJM"},{"issue":"06","key":"ref75","first-page":"973","article-title":"Shrinking lung syndrome in SLE\u2013a clinical pathologic study","volume":"10","author":"L A Rubin","year":"1983","journal-title":"J Rheumatol"},{"issue":"265","key":"ref76","first-page":"429","article-title":"Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus","volume":"71","author":"C M Laroche","year":"1989","journal-title":"Q J Med"},{"issue":"04","key":"ref77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/thorax.56.4.329","article-title":"Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes","volume":"56","author":"P Hawkins","year":"2001","journal-title":"Thorax"},{"issue":"10","key":"ref78","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1191\/0961203304lu1070cr","article-title":"Respiratory arrest in systemic lupus erythematosus due to phrenic nerve neuropathy","volume":"13","author":"R Omdal","year":"2004","journal-title":"Lupus"},{"issue":"02","key":"ref79","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1378\/chest.93.2.352","article-title":"Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus","volume":"93","author":"P G Wilcox","year":"1988","journal-title":"Chest"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41927-021-00240-0","article-title":"Myositis with prominent B-cell aggregates causing shrinking lung syndrome in systemic lupus erythematosus: a case report","volume":"6","author":"F Roy","year":"2022","journal-title":"BMC Rheumatol"},{"issue":"05","key":"ref81","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00006324-198905000-00002","article-title":"Cancellation of the boundary and edge effects by choice of lens thickness during oxygen permeability measurement of contact lenses","volume":"66","author":"B A Weissman","year":"1989","journal-title":"Optom Vis Sci"},{"issue":"05","key":"ref82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/sarh.2002.32555","article-title":"Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus","volume":"31","author":"M Y Karim","year":"2002","journal-title":"Semin Arthritis Rheum"},{"issue":"07","key":"ref83","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/0961203320919848","article-title":"Diaphragmatic muscle thickness and diaphragmatic function are reduced in patients with systemic lupus erythematosus compared to those with primary Sj\u00f6gren's syndrome","volume":"29","author":"H Sat\u0131\u015f","year":"2020","journal-title":"Lupus"},{"issue":"33","key":"ref84","doi-asserted-by":"crossref","first-page":"e4626","DOI":"10.1097\/MD.0000000000004626","article-title":"Shrinking lung syndrome in systemic lupus erythematosus: a case series and review of the literature","volume":"95","author":"H Borrell","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"02","key":"ref85","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000334947","article-title":"Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide","volume":"84","author":"E Langenski\u00f6ld","year":"2012","journal-title":"Respiration"},{"issue":"11","key":"ref86","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1177\/0961203314536248","article-title":"Shrinking lung syndrome presenting as an initial pulmonary manifestation of SLE","volume":"23","author":"S Pillai","year":"2014","journal-title":"Lupus"},{"issue":"07","key":"ref88","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1191\/0961203303lu1051oa","article-title":"Pulmonary hypertension in systemic lupus","volume":"13","author":"S R Johnson","year":"2004","journal-title":"Lupus"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1191\/096120300678828361","article-title":"Primary and secondary pulmonary hypertension in systemic lupus erythematosus","volume":"9","author":"T L Pan","year":"2000","journal-title":"Lupus"},{"issue":"04","key":"ref90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0049-0172(84)90015-5","article-title":"Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus","volume":"13","author":"F P Quismorio Jr","year":"1984","journal-title":"Semin Arthritis Rheum"},{"issue":"04","key":"ref91","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002960050074","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"18","author":"J Y Shen","year":"1999","journal-title":"Rheumatol Int"},{"issue":"07","key":"ref92","first-page":"918","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"16","author":"J S Simonson","year":"1989","journal-title":"J Rheumatol"},{"issue":"03","key":"ref93","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-8703(95)90278-3","article-title":"Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus","volume":"129","author":"T M Winslow","year":"1995","journal-title":"Am Heart J"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"854941","DOI":"10.1155\/2012\/854941","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction","volume":"2012","author":"A Dhala","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"12","key":"ref95","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/rheumatology\/kep203","article-title":"Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus","volume":"48","author":"A Prabu","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"03","key":"ref96","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11845-017-1727-4","article-title":"Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis","volume":"187","author":"T T Lv","year":"2018","journal-title":"Ir J Med Sci"},{"issue":"09","key":"ref97","first-page":"1923","article-title":"Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients","volume":"26","author":"E K Li","year":"1999","journal-title":"J Rheumatol"},{"issue":"04","key":"ref98","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0961203307087188","article-title":"An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?","volume":"17","author":"J Pope","year":"2008","journal-title":"Lupus"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"X211040696","DOI":"10.1177\/1759720X211040696","article-title":"Diagnosis and management of lung involvement in systemic lupus erythematosus and Sj\u00f6gren's syndrome: a literature review","volume":"13","author":"R Depascale","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/OARRR.S123549","article-title":"Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies","volume":"9","author":"K Tselios","year":"2016","journal-title":"Open Access Rheumatol"},{"issue":"05","key":"ref101","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/1756-185X.12262","article-title":"High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension","volume":"18","author":"K J Kim","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"25","key":"ref102","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"M M Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"ref103","first-page":"2417","article-title":"Sildenafil for pulmonary arterial hypertension associated with connective tissue disease","volume":"34","author":"D B Badesch","year":"2007","journal-title":"J Rheumatol"},{"issue":"04","key":"ref104","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0961203307076509","article-title":"Bosentan use in systemic lupus erythematosus patients with pulmonary arterial hypertension","volume":"16","author":"M Y Mok","year":"2007","journal-title":"Lupus"},{"issue":"02","key":"ref105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.126.2.420","article-title":"Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease","volume":"126","author":"R J Oudiz","year":"2004","journal-title":"Chest"},{"issue":"01","key":"ref106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.117.1.14","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus","volume":"117","author":"I M Robbins","year":"2000","journal-title":"Chest"},{"issue":"12","key":"ref107","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"L J Rubin","year":"2002","journal-title":"N Engl J Med"},{"issue":"06","key":"ref108","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3109\/s10165-012-0828-1","article-title":"Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center","volume":"23","author":"Y Shirai","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"02","key":"ref109","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/annrheumdis-2015-209087","article-title":"Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2","volume":"76","author":"M Humbert","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"03","key":"ref110","first-page":"e4327","article-title":"Systemic sclerosis and systemic lupus erythematosus overlap syndrome with pulmonary arterial hypertension successfully treated with immunosuppressive therapy and riociguat","volume":"11","author":"K Kuzuya","year":"2019","journal-title":"Cureus"},{"issue":"02","key":"ref111","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1191\/0961203304lu509oa","article-title":"Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus","volume":"13","author":"L Gonzalez-Lopez","year":"2004","journal-title":"Lupus"},{"issue":"09","key":"ref112","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/rheumatology\/kev097","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study","volume":"54","author":"S Kommireddy","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"02","key":"ref113","first-page":"267","article-title":"Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature","volume":"32","author":"M Prete","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"02","key":"ref114","first-page":"282","article-title":"Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment","volume":"29","author":"E Tanaka","year":"2002","journal-title":"J Rheumatol"},{"issue":"01","key":"ref115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.thromres.2014.10.012","article-title":"Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees","volume":"135","author":"H R Yusuf","year":"2015","journal-title":"Thromb Res"},{"issue":"03","key":"ref116","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11239-014-1050-0","article-title":"Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases","volume":"38","author":"H R Yusuf","year":"2014","journal-title":"J Thromb Thrombolysis"},{"issue":"07","key":"ref117","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/art.21149","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients","volume":"52","author":"J Calvo-Al\u00e9n","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"05","key":"ref118","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/096120339700600510","article-title":"Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus\u2013a meta-analysis","volume":"6","author":"D G Wahl","year":"1997","journal-title":"Lupus"},{"issue":"13","key":"ref119","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"V Pengo","year":"2018","journal-title":"Blood"},{"issue":"11","key":"ref120","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7326\/0003-4819-114-11-941","article-title":"Acute reversible hypoxemia in systemic lupus erythematosus","volume":"114","author":"S B Abramson","year":"1991","journal-title":"Ann Intern Med"},{"issue":"04","key":"ref121","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/096120339500400405","article-title":"Acute reversible hypoxemia in systemic lupus erythematosus: a new syndrome or an index of disease activity?","volume":"4","author":"V M Martinez-Taboada","year":"1995","journal-title":"Lupus"},{"issue":"02","key":"ref122","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/thorax.55.2.159","article-title":"Pleuropulmonary manifestations of systemic lupus erythematosus","volume":"55","author":"M P Keane","year":"2000","journal-title":"Thorax"},{"issue":"10","key":"ref123","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMra1007236","article-title":"Dysfunction of the diaphragm","volume":"366","author":"F D McCool","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"ref124","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/jcm5120113","article-title":"Diaphragm dysfunction: diagnostic approaches and management strategies","volume":"5","author":"B P Dub\u00e9","year":"2016","journal-title":"J Clin Med"},{"issue":"06","key":"ref125","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1378\/chest.97.6.1446","article-title":"Respiratory complications and management of spinal cord injuries","volume":"97","author":"J K Mansel","year":"1990","journal-title":"Chest"},{"issue":"03","key":"ref126","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0733-8619(18)30036-7","article-title":"Ventilatory management in critical neurologic illness","volume":"13","author":"C O Borel","year":"1995","journal-title":"Neurol Clin"},{"issue":"05","key":"ref127","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1378\/chest.94.5.1115a","article-title":"The diaphragm in SLE","volume":"94","author":"C M Laroche","year":"1988","journal-title":"Chest"},{"issue":"04","key":"ref128","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.semarthrit.2020.05.016","article-title":"Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER)","volume":"50","author":"V Torrente-Segarra","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"03","key":"ref129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jbspin.2017.05.012","article-title":"Pneumococcal infection in patients with systemic lupus erythematosus","volume":"85","author":"J Schurder","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"07","key":"ref130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0961203320922609","article-title":"Severe pneumonia in Chinese patients with systemic lupus erythematosus","volume":"29","author":"L Peng","year":"2020","journal-title":"Lupus"},{"issue":"14","key":"ref131","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1177\/0961203314543918","article-title":"Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections","volume":"23","author":"R KMAC Luijten","year":"2014","journal-title":"Lupus"},{"issue":"12","key":"ref132","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/annrheumdis-2021-222006","article-title":"EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update","volume":"81","author":"R BM Landew\u00e9","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"01","key":"ref133","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"V Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"04","key":"ref134","doi-asserted-by":"crossref","first-page":"2102776","DOI":"10.1183\/13993003.02776-2021","article-title":"Drug-induced interstitial lung disease","volume":"60","author":"P Spagnolo","year":"2022","journal-title":"Eur Respir J"},{"issue":"08","key":"ref135","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"M Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"06","key":"ref136","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients","volume":"35","author":"C Bombardier","year":"1992","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1782653.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T05:37:24Z","timestamp":1730785044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1782653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":135,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2024,5,22]]},"published-print":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1782653","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]}}}